Alexander Mark Schobel Aquestive Therapeutics, Inc. (AQST) insider trading activity
Alexander Mark Schobel is Chief Innovation/Tech Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 984,476 shares of AQST, which is worth approximately $2.76 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 50,000 shares (Common Stock) at a price of $6.0 per share, resulting in proceeds of $300,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
984K
0%
3M change
0.16%
12M change
Total Value Held
$2.76 Million
Alexander Mark Schobel Transaction History
AMS
Alexander Mark Schobel
Chief Innovation/Tech Officer
Warren, NJ